EA
TNDM icon

Emerald Acquisition’s Tandem Diabetes Care TNDM Stock Holding History

Emerald Acquisition’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$880K Sell
11,490
-1,257
-10% -$91.7K ﹤0.01% 2193
2016
Q2 		$961K Buy
+12,747
New +$1.03M ﹤0.01% 2197

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Emerald Acquisition's TNDM Position: Q3 2016 in Review

Emerald Acquisition reduced its Tandem Diabetes Care (TNDM) stake by 9.9% in Q3 2016, selling an estimated $91.7K and leaving 11,490 shares worth $880K. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

Emerald Acquisition first reported a position in TNDM in Q2 2016 and has held it in 2 quarters since. The position peaked at $961K in Q2 2016. 84 funds tracked by Wall St. Rank hold TNDM as of Q3 2016.

  • Emerald Acquisition held 11,490 shares of Tandem Diabetes Care worth $880K as of Q3 2016.
  • Emerald Acquisition sold 1,257 Tandem Diabetes Care shares in Q3 2016, an estimated $91.7K.
  • Tandem Diabetes Care made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2193 holding.
  • Emerald Acquisition first reported a position in Tandem Diabetes Care in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Tandem Diabetes Care position peaked at $961K in Q2 2016.
  • 84 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.